Kontroll og forutsigelse av frigjøring av AMC-109 fra biologisk nedbrytbare alifatiske polyestere

Offentlig prosjektsammendrag

The project addresses the need to reduce healthcare associated infections and is a collaboration between Amicoat AS, Chalmers University of Technology and RISE. The focus of the project is the encapsulation and controlled release of Amicoat's antimicrobial compound, AMC-109, from biodegradable aliphatic polyesters for medical devices. The project will involve encapsulating AMC-109 in into aliphatic polyesters, and incorporating them into various medical device prototypes, such as foams, nonwovens, coatings, and gels. The project will also measure, model, and predict the release and antimicrobial effect of AMC-109 from the microcapsules and the prototypes, using different analytical and experimental methods. If granted, the project would allow Amicoat to strengthen it’s competence allowing us to improve our abilities in enabling our customers to provide the world with antimicrobial medical devices and reduce the burden of healthcare associated infections.